GI Opportunity Fund 1

Overview

GI Opportunity Fund 1 is a venture capital fund established by the American Gastroenterological Association (AGA) to invest in gastrointestinal healthcare innovations. The fund aims to accelerate the development of early-stage companies by providing strategic investments ranging from $250,000 to $2 million, targeting pre-seed to Series B stages. This initiative seeks to bridge the funding gap often encountered by innovators in the gastrointestinal sector, facilitating the transition of promising concepts from development to clinical application. The fund's investment strategy focuses on sectors such as healthcare, medical devices, and biotechnology, with a particular emphasis on innovations that enhance patient care in the field of gastroenterology. By collaborating with Varia Ventures, the AGA offers its members the opportunity to participate in venture capital investments, thereby fostering a community-driven approach to advancing digestive health. This partnership underscores the AGA's commitment to supporting groundbreaking solutions that address the evolving needs of patients with digestive diseases. Since its inception, GI Opportunity Fund 1 has made several notable investments, including backing Virgo Surgical Video Solutions, a company specializing in AI-driven endoscopy capture and clinical trial platforms. This investment exemplifies the fund's dedication to supporting technologies that improve clinical workflows and patient outcomes in gastroenterology. Through such strategic investments, the fund continues to play a pivotal role in driving innovation and improving healthcare delivery within the gastrointestinal domain.

Investment Focus

• Innovations in gastrointestinal healthcare
• Early-stage companies
• Pre-seed to Series B stages
• Investment size between $250,000 and $2 million

Portfolio Companies